Antidepressant response and the serotonin transporter gene-linked polymorphic region

Biological Psychiatry

Volumn 68, Issue 6, 2010, Pages 536-543

  Taylor, Matthew J ^a   Sen, Srijan ^b   Bhagwagar, Zubin ^b,c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BRISTOL MYERS SQUIBB   (United States)

Author keywords

5 HTTLPR; Antidepressant; depression; meta analysis; polymorphism; treatment response

Indexed keywords

AGOMELATINE; AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DOSULEPIN; DOXEPIN; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; LOFEPRAMINE; MIANSERIN; MILNACIPRAN; MIRTAZAPINE; MOCLOBEMIDE; NEFAZODONE; NORTRIPTYLINE; PAROXETINE; PHENELZINE; REBOXETINE; SEROTONIN TRANSPORTER; SERTRALINE; TIANEPTINE; TRANYLCYPROMINE; TRAZODONE; VENLAFAXINE;

ARTICLE; GENE EXPRESSION; GENE INTERACTION; GENOTYPE; HUMAN; MAJOR DEPRESSION; POLYMORPHIC LOCUS; PRIORITY JOURNAL; PROMOTER REGION; REMISSION; SYSTEMATIC REVIEW; TREATMENT RESPONSE;

ALLELES; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; GENOTYPE; HUMANS; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; REMISSION INDUCTION; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 77956170298     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2010.04.034     Document Type: Article

References (61)

1. M.J. Taylor, N. Freemantle, J.R. Geddes, and Z. Bhagwagar Early onset of selective serotonin reuptake inhibitor antidepressant action: Systematic review and meta-analysis Arch Gen Psychiatry 63 2006 1217 1223
2. M.H. Trivedi, M. Fava, S.R. Wisniewski, M.E. Thase, F. Quitkin, and D. Warden Medication augmentation after the failure of SSRIs for depression N Engl J Med 354 2006 1243 1252
3. F. Holsboer How can we realize the promise of personalized antidepressant medicines? Nat Rev Neurosci 9 2008 638 646
4. A. Heils, A. Teufel, S. Petri, G. Stober, P. Riederer, D. Bengel, and K.P. Lesch Allelic variation of human serotonin transporter gene expression J Neurochem 66 1996 2621 2624
5. D.L. Murphy, A. Lerner, G. Rudnick, and K.P. Lesch Serotonin transporter: Gene, genetic disorders, and pharmacogenetics Mol Interv 4 2004 109 123
6. S. Lopez-Leon, A.C. Janssens, A.M. Gonzalez-Zuloeta Ladd, J. Del-Favero, S.J. Claes, B.A. Oostra, and C.M. van Duijn Meta-analyses of genetic studies on major depressive disorder Mol Psychiatry 13 2008 772 785
7. M.R. Munaf, N.B. Freimer, W. Ng, R. Ophoff, J. Veijola, and J. Miettunen Five-HTTLPR genotype and anxiety-related personality traits: A meta-analysis and new data Am J Med Genet B Neuropsychiatr Genet 150B 2009 271 281
8. M.R. Munafo, S.M. Brown, and A.R. Hariri Serotonin transporter (5-HTTLPR) genotype and amygdala activation: A meta-analysis Biol Psychiatry 63 2008 852 857
9. N. Risch, R. Herrell, T. Lehner, K.Y. Liang, L. Eaves, and J. Hoh Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: A meta-analysis JAMA 301 2009 2462 2471
10. K.A. Jennings, W.J. Sheward, A.J. Harmar, and T. Sharp Evidence that genetic variation in 5-HT transporter expression is linked to changes in 5-HT2A receptor function Neuropharmacology 54 2008 776 783
11. E. Smeraldi, R. Zanardi, F. Benedetti, D. Di Bella, J. Perez, and M. Catalano Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine Mol Psychiatry 3 1998 508 511
12. A. Serretti, M. Kato, D. De Ronchi, and T. Kinoshita Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients Mol Psychiatry 12 2007 247 257
13. X.Z. Hu, A.J. Rush, D. Charney, A.F. Wilson, A.J. Sorant, and G.J. Papanicolaou Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression Arch Gen Psychiatry 64 2007 783 792
14. R Development Core Team R: A Language and Environment for Statistical Computing 2009 Vienna, Austria
15. G. Schwarzer Meta: Meta-Analysis R Package, Version 0.919 http://CRAN.R-project.org/package=meta 2009 Last accessed June 9, 2010
16. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 2003 557 560
17. J.A. Sterne, and M. Egger Funnel plots for detecting bias in meta-analysis: Guidelines on choice of axis J Clin Epidemiol 54 2001 1046 1055
18. R.M. Harbord, M. Egger, and J.A. Sterne A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints Stat Med 25 2006 3443 3457
19. S. Duval, and R. Tweedie Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis Biometrics 56 2000 455 463
20. B.S. Everitt, and T. Hothorn A Handbook of Statistical Analyses Using R 2006 Chapman & Hall Boca Raton, Florida
21. S.G. Thompson, and J.P. Higgins How should meta-regression analyses be undertaken and interpreted? Stat Med 21 2002 1559 1573
22. D.K. Kim, S.W. Lim, S. Lee, S.E. Sohn, S. Kim, C.G. Hahn, and B.J. Carroll Serotonin transporter gene polymorphism and antidepressant response Neuroreport 11 2000 215 219
23. B.G. Pollock, R.E. Ferrell, B.H. Mulsant, S. Mazumdar, M. Miller, and R.A. Sweet Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression Neuropsychopharmacology 23 2000 587 590
24. R. Zanardi, F. Benedetti, D. Di Bella, M. Catalano, and E. Smeraldi Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gene J Clin Psychopharmacol 20 2000 105 107
25. R. Zanardi, A. Serretti, D. Rossini, L. Franchini, C. Cusin, and E. Lattuada Factors affecting fluvoxamine antidepressant activity: Influence of pindolol and 5-HTTLPR in delusional and nondelusional depression Biol Psychiatry 50 2001 323 330
26. J.L. Rausch, M.E. Johnson, Y.J. Fei, J.Q. Li, N. Shendarkar, and H.M. Hobby Initial conditions of serotonin transporter kinetics and genotype: Influence on SSRI treatment trial outcome Biol Psychiatry 51 2002 723 732
27. K. Yoshida, K. Ito, K. Sato, H. Takahashi, M. Kamata, and H. Higuchi Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients Prog Neuropsychopharmacol Biol Psychiatry 26 2002 383 386
28. Y.W. Yu, S.J. Tsai, T.J. Chen, C.H. Lin, and C.J. Hong Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders Mol Psychiatry 7 2002 1115 1119
29. B. Arias, R. Catalan, C. Gasto, B. Gutierrez, and L. Fananas 5-HTTLPR polymorphism of the serotonin transporter gene predicts non-remission in major depression patients treated with citalopram in a 12-weeks follow up study J Clin Psychopharmacol 23 2003 563 567
30. P.R. Joyce, R.T. Mulder, S.E. Luty, J.M. McKenzie, A.L. Miller, G.R. Rogers, and M.A. Kennedy Age-dependent antidepressant pharmacogenomics: Polymorphisms of the serotonin transporter and G protein beta3 subunit as predictors of response to fluoxetine and nortriptyline Int J Neuropsychopharmacol 6 2003 339 346
31. L.K. Durham, S.M. Webb, P.M. Milos, C.M. Clary, and A.B. Seymour The serotonin transporter polymorphism, 5HTTLPR, is associated with a faster response time to sertraline in an elderly population with major depressive disorder Psychopharmacology 174 2004 525 529
32. M.S. Lee, H.Y. Lee, H.J. Lee, and S.H. Ryu Serotonin transporter promoter gene polymorphism and long-term outcome of antidepressant treatment Psychiatr Genet 14 2004 111 115
33. A. Serretti, R. Zanardi, L. Franchini, P. Artioli, D. Dotoli, A. Pirovano, and E. Smeraldi Pharmacogenetics of selective serotonin reuptake inhibitor response: A 6-month follow-up Pharmacogenetics 14 2004 607 613
34. J.B. Kraft, S.L. Slager, P.J. McGrath, and S.P. Hamilton Sequence analysis of the serotonin transporter and associations with antidepressant response Biol Psychiatry 58 2005 374 381
35. M. Kato, T. Fukuda, M. Wakeno, K. Fukuda, G. Okugawa, and Y. Ikenaga Effects of the serotonin type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese patients Neuropsychobiology 53 2006 186 195
36. H. Kim, S.W. Lim, S. Kim, J.W. Kim, Y.H. Chang, B.J. Carroll, and D.K. Kim Monoamine transporter gene polymorphisms and antidepressant response in Koreans with late-life depression JAMA 296 2006 1609 1618
37. C.H. Ng, S. Easteal, S. Tan, I. Schweitzer, B.K. Ho, and S. Aziz Serotonin transporter polymorphisms and clinical response to sertraline across ethnicities Prog Neuropsychopharmacol Biol Psychiatry 30 2006 953 957
38. J. Popp, S. Leucht, S. Heres, and W. Steimer Serotonin transporter polymorphisms and side effects in antidepressant therapyA pilot study Pharmacogenomics 7 2006 159 166
39. X.Z. Hu, R.H. Lipsky, G. Zhu, L.A. Akhtar, J. Taubman, and B.D. Greenberg Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder Am J Hum Genet 78 2006 815 826
40. C.J. Hong, T.J. Chen, Y.W. Yu, and S.J. Tsai Response to fluoxetine and serotonin 1A receptor (C-1019G) polymorphism in Taiwan Chinese major depressive disorder Pharmacogenomics J 6 2006 27 33
41. J. Kirchheiner, K. Nickchen, J. Sasse, M. Bauer, I. Roots, and J. Brockmoller A 40-basepair VNTR polymorphism in the dopamine transporter (DAT1) gene and the rapid response to antidepressant treatment Pharmacogenomics J 7 2007 48 55
42. N. Bozina, A.M. Peles, M. Sagud, H. Bilusic, and M. Jakovljevic Association study of paroxetine therapeutic response with SERT gene polymorphisms in patients with major depressive disorder World J Biol Psychiatry 9 2008 190 197
43. R.H. Kang, M.L. Wong, M.J. Choi, J.W. Paik, and M.S. Lee Association study of the serotonin transporter promoter polymorphism and mirtazapine antidepressant response in major depressive disorder Prog Neuropsychopharmacol Biol Psychiatry 31 2007 1317 1321
44. O. Dogan, N. Yuksel, M.A. Ergun, A. Yilmaz, M.N. Ilhan, and H.E. Karslioglu Serotonin transporter gene polymorphisms and sertraline response in major depression patients Genet Test 12 2008 225 231
45. M.J. Wilkie, G. Smith, R.K. Day, K. Matthews, D. Smith, and D. Blackwood Polymorphisms in the SLC6A4 and HTR2A genes influence treatment outcome following antidepressant therapy Pharmacogenomics J 9 2009 61 70
46. H.G. Ruhe, W. Ooteman, J. Booij, M.C. Michel, M. Moeton, F. Baas, and A.H. Schene Serotonin transporter gene promoter polymorphisms modify the association between paroxetine serotonin transporter occupancy and clinical response in major depressive disorder Pharmacogenet Genomics 19 2009 67 76
47. E. Maron, A. Tammiste, K. Kallassalu, T. Eller, V. Vasar, D.J. Nutt, and A. Metspalu Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depression Eur Neuropsychopharmacol 19 2009 451 456
48. P. Huezo-Diaz, R. Uher, R. Smith, M. Rietschel, N. Henigsberg, and A. Marusic Moderation of antidepressant response by the serotonin transporter gene Br J Psychiatry 195 2009 30 38
49. M.R. Munaf, C. Durrant, G. Lewis, and J. Flint Gene X environment interactions at the serotonin transporter locus Biol Psychiatry 65 2009 211 219
50. K.M. Smits, L.J. Smits, F.P. Peeters, J.S. Schouten, R.G. Janssen, and H.J. Smeets The influence of 5-HTTLPR and STin2 polymorphisms in the serotonin transporter gene on treatment effect of selective serotonin reuptake inhibitors in depressive patients Psychiatr Genet 18 2008 184 190
51. K.A. Jennings, M.K. Loder, W.J. Sheward, Q. Pei, R.M. Deacon, and M.A. Benson Increased expression of the 5-HT transporter confers a low-anxiety phenotype linked to decreased 5-HT transmission J Neurosci 26 2006 8955 8964
52. K. Shioe, T. Ichimiya, T. Suhara, A. Takano, Y. Sudo, and F. Yasuno No association between genotype of the promoter region of serotonin transporter gene and serotonin transporter binding in human brain measured by PET Synapse 48 2003 184 188
53. S.J. Bull, P. Huezo-Diaz, E.B. Binder, J.F. Cubells, G. Ranjith, and C. Maddock Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment Mol Psychiatry 14 2008 1095 1104
54. F.J. McMahon, S. Buervenich, D. Charney, R. Lipsky, A.J. Rush, and A.F. Wilson Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment Am J Hum Genet 78 2006 804 814
55. S. Paddock, G. Laje, D. Charney, A.J. Rush, A.F. Wilson, and A.J. Sorant Association of GRIK4 with outcome of antidepressant treatment in the STAR (*) D cohort Am J Psychiatry 164 2007 1181 1188
56. E.B. Binder, D. Salyakina, P. Lichtner, G.M. Wochnik, M. Ising, and B. Putz Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment Nat Genet 36 2004 1319 1325
57. L. Mandelli, E. Marino, A. Pirovano, R. Calati, R. Zanardi, C. Colombo, and A. Serretti Interaction between SERTPR and stressful life events on response to antidepressant treatment Eur Neuropsychopharmacol 19 2009 64 67
58. G.S. Sachs, A.A. Nierenberg, J.R. Calabrese, L.B. Marangell, S.R. Wisniewski, and L. Gyulai Effectiveness of adjunctive antidepressant treatment for bipolar depression N Engl J Med 356 2007 1711 1722
59. J.P. Ioannidis, E.E. Ntzani, T.A. Trikalinos, and D.G. Contopoulos-Ioannidis Replication validity of genetic association studies Nat Genet 29 2001 306 309
60. R.J. Light, and D.B. Pillemer Summing Up The Science of Reviewing Research 1984 Harvard University Press Cambridge, Massachusetts
61. J.A. Sterne, M. Egger, and G.D. Smith Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis BMJ 323 2001 101 105